Enzo Biochem Stock Price and Value Analysis

Should you buy Enzo Biochem stock? (NYSE:ENZ). Let's see how it does in our automated value investing analysis system.

ENZ Free Cash Flow Trend

Free Cash Flow trendline for ENZ
Free Cash Flow trendline for Enzo Biochem

Hmm, we can't give any reliable projection for Enzo Biochem's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

  • This company has fluctuating growth.
  • This company is solid.
  • This stock looks overpriced.
  • This company is not making money.
  • This company pays no dividend.

Inside the ENZ Numbers

ENZ Price
(Enzo Biochem stock price per share)
PE Ratio versus Sector 253% higher than other Healthcare stocks
PE Ratio versus Industry 93% lower than other Diagnostics & Research stocks
Cash Yield -1.10%
Free Cash Flow Jitter 27%

Is Enzo Biochem Stock on Sale?

Based on our analysis, we believe that you should not buy Enzo Biochem right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy ENZ Stock?

Does Enzo Biochem have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.